Clinical periodontitis is associated with an increased risk for cardiovascular diseases (CVDs) through systemic inflammation as the etiopathogenic link. Whether the oral microbiota, especially its quality, quantity, serology, and virulence factors, plays a role in atherogenesis is not clarified. Patients with periodontitis are exposed to bacteria and their products, which have access to the circulation directly through inflamed oral tissues and indirectly (via saliva) through the gastrointestinal tract, resulting in systemic inflammatory and immunologic responses. Periodontitis is associated with persistent endotoxemia, which has been identified as a notable cardiometabolic risk factor. The serology of bacterial biomarkers for oral dysbiosis is associated with an increased risk for subclinical atherosclerosis, prevalent and future coronary artery disease, and incident and recurrent stroke. In addition to speciesspecific antibodies, the immunologic response includes persistent, cross-reactive, proatherogenic antibodies against host-derived antigens. Periodontitis may affect lipoprotein metabolism at all levels, and all lipoprotein classes are affected. Periodontitis or its bacterial signatures may be involved not only in increased storage of proatherogenic lipids but also in attenuation of the anti-atherogenic processes, thereby putatively increasing the net risk of atherosclerosis. In this review we summarize possible molecular mediators between the dysbiotic oral microbiota and atherosclerotic processes.
Periodontal diseases initiate and propagate through dysbiosis of the oral microbiota (1) . The interactions with the host immune defences involve pathways that have been recognized as proatherogenic. Atherosclerosis -a crosstalk between cholesterol accumulation and inflammation (2) -is the most frequent cause of cardiovascular diseases (CVDs). As both periodontitis and CVD are chronic diseases that develop slowly, having already started in the teenage years, the temporal sequence is not known. However, periodontitis is associated with increased risk for CVD in meta-analyses. The relative summary risk estimates for coronary artery disease (CAD) indicate a significant 24% and 34% risk increase in periodontitis and advanced tooth loss, respectively (3) . The relative risk for ischemic stroke was also significantly increased with varying risk estimates depending on the types of study design (4) . According to an American Heart Association statement, the association is independent of known confounders (5) .
There is some evidence that the CVD risk factors can be reduced with by proper periodontal treatment: according to a meta-analysis, periodontal treatment improved plasma concentrations of inflammatory [C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a)], thrombotic (fibrinogen), and metabolic [triglycerides, total cholesterol, highdensity lipoprotein (HDL) cholesterol, glycated hemoglobin (HbA1c)] markers and stimulated recovery of endothelial function (6) . The beneficial effects of treatment seemed to be more pronounced in patients with comorbidities (6) . However, another meta-analysis considered these improvements as limited and the authors called for more studies on the long-term effects of periodontal treatment on CVD burden (7) . The Periodontitis and Vascular Events (PAVE) study, a randomized pilot trial (n = 303), investigated the effect of periodontal treatment on secondary CVD events (8) . The primary outcomes, adverse cardiovascular events, occurred with equal frequency in both treatment groups, whereas more serious adverse events were registered in the community control group. The result was, however, non-significant (8) , and the secondary outcome, the decrease of serum CRP concentration, was critically confounded by obesity (9) . These results demonstrate only some of the challenges encountered in randomized controlled trials (RCT) which may include heterogeneity of both the patient populations and composite end points, such as major adverse cardiac events (10) . Nevertheless, the sa1me researchers published recently how regular dental-care utilization (one or more annual visits) compared with episodic care is significantly associated with lower adjusted risk for incident stroke (11) . An observation related to this was also seen in our recent cross-sectional study, in which the risk of incident stroke was highest among subjects reporting that they never visit a dentist (OR = 4.5; 95% CI: 2.4-8.3) (12) .
According to current consensus, the etiopathogenic link between periodontitis and CVD is low-grade systemic inflammation. Proinflammatory mediators are produced locally in the periodontal tissues and, in addition to their leakage to oral cavity and saliva, they spread into the circulation and promote inflammatory processes that disturb metabolic regulation. Chronic inflammation leads to significant cytokineinduced alterations, for example in lipoproteins, which play central roles in the host immune responses. Inflammation affects all lipoprotein classes (13) (14) (15) (16) , resulting in similar (but milder) changes than during the acute phase (Fig. 1) . The modifications in the distribution and composition of the lipoproteins affect their ligand properties, and because inflammation also decreases the levels of multiple receptors expressed, the clearance of lipoprotein is affected, resulting in a proatherogenic lipoprotein profile (13) . In human and animal studies, periodontitis or its dysbiotic bacteria are involved not only in increased uptake and storage of proatherogenic lipids but also in attenuation of the anti-atherogenic processes (14) (15) (16) (17) (18) (19) (20) . These alterations occur to protect the host from harmful effects of microbes but in the long term they probably increase the risk of atherosclerosis (13) . An association between periodontitis and unbalanced lipoprotein metabolism seems to concern especially apo(lipoprotein)B-100-containing lipoprotein classes, very-lowdensity lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and low-density lipoprotein (LDL) (21, 22) .
Common susceptibility may explain some of the association between periodontitis and CVD. According to this hypothesis there is a genetically determined phenotype that predisposes to both atherosclerosis and immune hyperresponsiveness of the host to pathogens. To investigate this is challenging because both diseases are polygenic, meaning that they are associated with multiple genetic variations, each of which has a small contribution to the disease risk. A variation of similar clinical characters may derive from mild-to-severe forms of the disease with different genetic backgrounds (23) . In both diseases, of course, the risk factors deriving from the lifestyle play a large role, without forgetting the possibility that environment modifies the epigenomes (24) or the host/pathogen interactome (25) . To date, genome-wide association (GWA) or large-scale candidate gene studies have linked periodontitis significantly with variation in only four genes (26) . Three of the loci have also been associated with CAD risk, and the one most often replicated is the variation observed in the 9p21.3 locus (26-28).
Oral microbiota and CVD
Systemic low-grade inflammation is associated with periodontitis (6), but less is known about a direct contribution of the oral microbiota in CVD. Periodontal bacteria have repeatedly been found in atherosclerotic lesions, but some studies have also failed to detect them (5) . Transient bacteremia is common after dental treatment procedures, such as a periodontal examination or a tooth extraction (29-31), and also after mastication or toothbrushing (30, 32). Involvement of atherosclerotic plaque bacteria in atherogenesis is not clear: are they viable, do they need to be, are the species important, is the number of species more important, or are they just markers of exposure? Nevertheless, the amount of bacterial DNA in the atherosclerotic plaque correlates with the number of leukocytes present, suggesting that the bacteria may participate in the local immune response (33). As periodontitis is associated with dysbiosis of the commensal species, it is feasible to hypothesize that the subgingival microbiota plays a role in systemic inflammation and atherogenesis. In a large study by DESVARIEUX and coworkers, an overall subgingival bacterial burden (11 species) was not associated with CRP concentration or white blood cell count (34). In a more recent work, a systemic inflammatory score was inversely associated with actinobacteria and proteobacteria and directly with Firmicutes and the candidate phylum, TM7 (35). Before correction for multiple comparisons, the study revealed 18 individual taxa associating with the inflammatory score. Although some associations were unexpected, the results show that the subgingival microbiota may have significance in systemic inflammation. The traditional periodontal bacteria, however, were not among those associating with the score.
In a few studies, the oral microbiota has been associated directly with CVD outcomes. The periodontal pathogen burden has been linked with stable CAD, acute coronary syndrome (ACS), and subclinical atherosclerosis (34, 36-38). Some studies have identified single species that associate with CAD (36, 39-41). Pyrosequencing of bacterial 16S rRNA genes in oral swabs did not reveal significant differences between patients with atherosclerosis and controls, but in patients with symptomatic atherosclerosis the bacteria genus Anaeroglobus was more abundant than in controls (42). Importantly, subclinical atherosclerosis decreased with improvement in clinical and microbial periodontal status in a 3-yr follow-up (43).
Lipopolysaccharide as a mediator
Lipopolysaccharide (LPS) is an endotoxin and an important virulence factor of gram-negative bacteria. All LPS molecules consist of three main parts: an Oantigen; a core polysaccharide; and a lipid A. The lipid A integrates LPS into the outer membrane of the bacterial cell and is mainly responsible for the toxicity of the molecule, inducing physiological symptoms of illness Mediators between oral dysbiosis and CVD such as fever, muscle aches, and nausea. The O-antigen is the most variable structure of the molecule and a potent antigen in acquired immunity. Lipopolysaccharide is capable of acting as an immunostimulator or immunomodulator, thereby contributing to the virulence of the species (44). Importantly, LPS belongs to the pathogen-associated molecular patterns (PAMPs) recognized by the first-line defence mechanisms of the innate immune system. The binding of LPS to toll-like receptor-4 (TLR-4) leads to the downstream activation of a generalized inflammatory response with synthesis of a variety of proinflammatory mediators, such as TNF-a and interleukins. When released into the circulation these mediators activate the acute phase response, the complement system, the coagulation cascade, and leukocyte migration, in order to eradicate the invading bacteria (45) .
Translocation of LPS in the circulation is called endotoxemia, which may arise from either infections or commensal bacteria. The role of the oral cavity as a source of endotoxemia is being actively investigated (Fig. 1 ). The mouth harbors approximately 100-200 different commensal bacterial species (46) and incorporates a higher phylogenetic diversity than any location in the body (47) . Even though new exogenous species are being introduced on a daily basis, the salivary microbiota persists and is stable over time (48) and represents the whole oral microbiota fairly well (49) . The salivary bacterial concentration is approximately 10 9 colony-forming units (CFUs) per ml, and approximately 1 l of saliva is swallowed per day (50) . Saliva contains large amounts of LPS (41) and its biological activity is 10,000-fold higher than that of serum (51) . In vitro experiments suggest that LPS retains its biological activity following protease or low-pH treatment, thereby possibly contributing to TLR stimulation of the small intestine (50, 52, 53) . The relative amount of 70 different subgingival bacterial species was recently correlated with salivary LPS activity (51) . Interestingly, only the abundance of typical gram-negative oral residents, especially classical periodontal pathogens, seemed to have a high relative impact on salivary LPS activity (51) .
Patients with periodontitis suffer from persistent endotoxemia (15, 54, 55) as a result of the presence of large number of gram-negative species in the oral microbiota (56) which hypothetically have direct access to the circulation through inflamed periodontium (Fig. 1 ). Bacteria and their antigenic components may also translocate via lymph vessels. Furthermore, some of the species associated with periodontitis, such as Porphyromonas gingivalis, are able to invade and replicate in epithelial cells (57) . Oral challenge by P. gingivalis has been shown to alter the composition of gut microbiota by increasing the proportions of the phylum Bacteroidetes at the expense of the phylum Firmicutes with a concomitant increase in serum endotoxin activity (58) . The routes of periodontitis-associated endotoxemia may be diverse, but concomitantly the oral dysbiosis observed in periodontitis may reflect a more widely imbalanced microbiome.
In the circulation, LPS can be recovered from bacterial cell walls, fragments of bacterial outer membrane, outer membrane vesicles, bound to either bacterial or host proteins, or from blood cells (59) . Most of the LPS activity is found among lipoproteins (60), especially HDL (61) , which contribute to the neutralization of the activity by preventing lipid A from interacting with TLR-4 (62). The distribution may, however, be different during inflammatory, infectious, or metabolic diseases (21, 63, 64) . Therefore, detoxification of LPS depends at least on the inflammatory state, the lipoprotein and apolipoprotein profile, and the concentrations of LPS-binding proteins (65) .
The endotoxemia levels vary from the moderate increases found in 'metabolic endotoxemia' to the activities of >100-fold found in sepsis (66, 67) . Although the oral cavity may contribute to endotoxemia, especially in patients with periodontitis, the main endogenous origin of endotoxins is probably the gut microbiota (68) . The presence of local inflammation or an unhealthy diet are probable prerequisites for endotoxemia (56, 69, 70) . Metabolic endotoxemia results in a status with chronic low-grade proinflammation and pro-oxidative stress (71) , which may contribute to vasodilation and increased vascular and intestinal permeability. The inflammation associated with endotoxemia may partly explain its previously shown associations with clinical outcomes, such as CVD (70, 72, 73) , progression of renal disease in diabetic subjects (74) , and metabolic disorders, such as diabetes (75-77), obesity (66, 70, 78), metabolic syndrome (70, 75, 79) , and non-alcoholic fatty liver disease (80) . Serum LPS activity is indirectly associated with serum HDL cholesterol concentrations and directly with triglyceride, cholesterol, CRP (73), fasting glucose, insulin, and HbA1c concentrations, as well as with body mass index (70, 79) , especially with the mass of visceral fat (81) . Interestingly, serum LPS activity correlates with the levels of serum IgG against P. gingivalis (73).
Therefore, LPS is considered a molecular link between the microbiome and cardiometabolic disorders (65, 69) . For example, salivary LPS has been shown to correlate with serum LPS activity, and this association was enhanced when periodontal disease was present (51) . This finding supports the logic that an abundance of oral gram-negative bacteria increases local levels of proinflammatory LPS molecules, which are -one way or the other -dispersed into the circulation, ultimately increasing the risk of CAD (82) . This chain of events has been observed, using a bootstrapping-based formal statistical test of mediation, to eliminate bias caused by small sample size, skewed distribution, or multiple comparisons error (83) , further supporting the hypothesis that the oral microbiota has a role in CVD.
Other bacterial antigens as mediators
Other virulence factors and bacterial components are probably also involved in systemic inflammatory processes and atherogenesis. At least Aggregatibacter actinomycetemcomitans, Tannerella forsythia, Treponema denticola, and P. gingivalis release outer membrane vesicles (OMVs) (84) (85) (86) . In addition to comprising parts of the membrane, OMVs are composed of bacterial proteins, LPS, fatty acids, nucleic acids, peptidoglycan fragments, fimbriae, adhesins, capsule, and speciesspecific virulence factors, such as cytolethal distending toxin (CDT), leukotoxin (LtxA), and gingipain (84) (85) (86) . Outer membrane vesicles are important both in bacteria-bacteria and bacteria-host interactions (87) . They utilize multiple means to enter the host cells and deliver their cargo (88) . Outer membrane vesicles deriving from different bacteria and strains have different PAMPs that induce varying inflammatory responses via diverse pattern recognition receptors (PRRs) (84) . For example, bacteria of the phylum Bacteroidetes produce serine dipeptide lipids that are recognized by TLR-2 (89). These lipid forms are common in some P. gingivalis strains and they have also been recovered in carotid endarterectomy samples (90) .
Molecular mimicry
Indirect interactions of periodontal pathogens in CVD include both innate and adaptive immune responses. All bacterial structural components and virulence factors are recognized as antigens and they give rise to antibody production, both locally in oral fluids and Mediators between oral dysbiosis and CVD systemically in serum. It is not entirely clear whether the antibodies in the end are protective or how they participate in the pathogenesis of periodontitis and other chronic diseases associated with periodontitis. The proportion or contribution of antibodies produced against host-derived antigens in response to sequence or epitope similarities with pathogen-derived antigens is also indistinct. The cross-reactive antibodies are part of an immunological process called molecular mimicry, which promotes inflammation and may have a role in atherogenesis. One of the epitopes most often studied is present in the heat shock proteins (HSPs), which are found in virtually all living organisms, from bacteria to humans. These proteins were first described as a response to heat shock, but they are also expressed during tissue remodeling and wound healing, and in response of cells to stressful conditions, including oxidative stress (91). At least eight HSP family members have been associated with CVD (92), but the most frequently investigated is the HSP60. It has been suggested that HSP60-reactive T cells play a role in initial atherosclerosis, whereas antibodies to HSP60 accelerate the atherosclerotic process by promoting infiltration of mononuclear cells into intima (91) .
GroEL proteins of the HSP60 family have been identified as major antigens in several periodontitis-associated bacterial species (93, 94) , and a natural monoclonal IgM to oxidized LDL has been shown to recognize the HSP60 chaperon of A. actinomycetemcomitans (95). One study found salivary HSP60-IgA to be higher in gingivitis than in periodontal health, but no difference was found in another study (96, 97) . Serum antibody titers to HSP90, HSP70, and P. gingivalis LPS were suggested to be useful in predicting the response to periodontal therapy (98) . Some studies have found a difference in the levels of serum HSP antibody between patients with and without periodontitis, whereas other studies have failed to find a difference (99) (100) (101) (102) (103) . When the risk factors of periodontitis were considered, serum HSP65-IgA and IgG 1 associated significantly with periodontitis, whereas HSP60-IgG 2 associated with periodontal health (103) . The levels of A. actinomycetemcomitans and HSP60 antibody correlated with each other, but in one study the presence of the bacterium in saliva had no effect on the levels of HSP60 antibody (101), whereas in another study, the levels of HSP60 antibody correlated with both periodontal pocketing and subgingival bacterial burden (102) .
Other epitopes giving rise to cross-reactivity between the bacteria and the host are found in LDL. When LDL accumulates in the vascular wall, it becomes modified by enzymes and non-enzymatically by free radicals, generating immunogenic structures (104) . The concept oxidized-LDL (oxLDL) comprises a heterogeneous range of reaction products because all oxidationsensitive components of the particle, including both protein (apoB100) and lipid (cholesterol, phospholipids, fatty acids) moieties can be oxidized to various degrees (105) . The presence of oxLDL in atherosclerotic plaques was first shown in 1989 (106) . Natural antibodies of the IgM class, which are pentamers, may prevent the uptake of oxLDL by macrophages, whereas antibodies of the IgG class promote the uptake of immune complexes that they form with oxLDL (107) . Therefore, IgM to oxLDL are considered as atheroprotective and IgG to oxLDL are considered as proatherogenic (108, 109) .
Frequently used models of oxLDL include the dominant epitopes malondialdehyde (MDA) and malondialdehyde acetaldehyde (MAA), which are efficiently recognized by various arms of the immune system (104) . Antibodies representing either the IgM or the IgG class recognize epitopes present not only in oxLDL but also in periodontal bacteria (110) . IgM that bind to these epitopes are already present before birth (111) . A natural monoclonal IgM to MDA-LDL has been shown to recognize arginine-specific gingipain domains of P. gingivalis (112, 113) . Proteolytic enzymes of P. gingivalis, especially the arginine-specific gingipain, are able to modify LDL particles, resulting in oxidation (114) . In further mouse studies, immunization with inactivated P. gingivalis was shown to protect mice from diet-induced atherosclerosis, and immunization with oxLDL protected mice from P. gingivalis-induced atherosclerosis as a result of production of the IgM (112, 115) .
Antibodies cross-reacting between oxLDL epitopes and P. gingivalis gingipain are also present in human saliva and plasma (112, 116) . Serum antibody titers to gingipains associate with myocardial infarction independently of periodontal status (117) . Other epitopes suggested to be involved in proatherogenic antibody responses in periodontitis include cardiolipin, b 2 -glycoprotein I (apoH), and phosphocholine (94) . In our case-control study, in which the levels of 21 different antibodies were determined, IgG levels to A. actinomycetemcomitans, P. gingivalis, and oxLDL (epitopes induced by MDA and copper) were significantly associated with periodontitis (103) . All antibody levels were remarkably stable during the 6-month periodontal treatment. This has also been observed in other studies, whether comprising treatment or not (118) (119) (120) (121) . The levels of antibody to A. actinomycetemcomitans and P. gingivalis are determined primarily by the presence of the bacterium and secondly by the signs of periodontitis (122) . However, the contribution of the oral microbiota to the levels of cross-reacting antibody has not been studied in detail.
Periodontal bacteria as antigens
Regarding CVD outcomes, antibody levels to A. actinomycetemcomitans and P. gingivalis are those most often studied (Fig. 1) . IgA seropositivity to these species predicted incident and recurrent stroke, incident myocardial infarction, and incident CAD events (123) (124) (125) (126) (127) . In cross-sectional studies, serum A. actinomycetemcomitans antibody levels were also associated with metabolic syndrome (128) and with manifestations of both stable and acute CAD (41).
The immunologic burden comprising either cumulative or combined antibody responses to several oral species has been reported in a few articles. High antibody levels to selected species have been shown to correlate with the carotid artery intima media thickness, a sign of subclinical atherosclerosis (126, 129) , with coronary artery calcification (130) , and with low HDL cholesterol concentration (131) . High combined IgG response to A. actinomycetemcomitans and P. gingivalis was associated with prevalent CAD (132) . This combination also independently predicted incident CVD events in a 10-yr follow-up study, and the hazards increased markedly when high concentrations of CRP or IL-6 were considered in the calculations (73) . In studies including several species, elevated antibody levels were associated with a history of myocardial infarction (133) and with CAD (134) among patients with HIV (135) . In a study in which viral antibodies were associated with acute coronary events but not with the degree of coronary pathologies, the highest IgA-class antibody levels to A. actinomycetemcomitans, Chlamydia pneumoniae HSP60, and human HSP60 were associated with coronary obstruction and occlusion (136) . This suggests that clinical coronary events may involve an acute inflammatory stimulus, but obstruction of atherosclerotic lesions results from chronic provocation (136) . Another study found, however, that IgG or IgA burdens composed of antibody levels against four periodontal species did not significantly associate with the extent of coronary atherosclerosis, coronary plaque vulnerability, or major adverse cardiac events in a 1-yr follow-up (137) .
In a recent study, we found, in confounder-adjusted analyses, that the combined serum antibody levels to A. actinomycetemcomitans, P. gingivalis, Porphyromonas endodontalis, Prevotella intermedia, T. forsythia, Campylobacter rectus, and Fusobacterium nucleatum indicated past or present periodontal disease and was associated with the acute coronary syndrome (138) . A formal statistical test of mediation showed that the subgingival abundance of these species had a statistically significant indirect effect on acute coronary syndrome through the corresponding systemic IgA burden (83) , suggesting that the deleterious effects of the periodontal microbiota on CVD could be partly mediated by the adaptive immune response. It has been concluded that the IgA response depicts recent or repeated exposure to the antigen because this antibody class has a short halflife. Supporting this, the IgA response against C. pneumoniae is considered as a marker of a persistent/chronic infection (139) .
The 'infectious burden', comprising several infectious organisms, is believed to have a stronger association with CVD than exposure to a single microbe (140) . The contribution of the antibody response against oral species to the infectious burden has seldom been studied. In a recent study, we found an infectious burden composed of cumulative IgA seropositivity to A. actinomycetemcomitans, P. gingivalis, C. pneumoniae, Mycoplasma pneumoniae, and Helicobacter pylori to be associated with an increased risk for incident ischemic stroke as a result of large vessel disease, but the finding was not independent of disadvantageous childhood socio-economic status (12) . To reveal the complex immune responses linking periodontitis with CVD we would need to utilize new technologies and approaches. Such could be the mimotope variation analysis (MVA) resulting in quantitative serological immune profiles including millions of peptide antigens from a small serum aliquot and without the prerequisite of antigen selection (141) .
The serological data suggest that A. actinomycetemcomitans has a distinct role in CVD. Both A. actinomycetemcomitans and its LPS have been shown to promote innate immune signaling, proatherogenic lipoprotein profiles, aortic inflammation, lipid peroxidation, and atherosclerotic plaque formation in apoE-deficient mice (142, 143) . To date, seven serotypes (a-g) of A. actinomycetemcomitans have been identified with varying gene content, distribution of genomic islands, and presence of virulence factors (144) (145) (146) (147) (148) . The association between different A. actinomycetemcomitans serotypes and the risk for systemic diseases, such as CVD, has rarely been studied, although the immune response against diverse strains and serotypes of the species may vary considerably (149) . Previous studies indicate that serotype c is related to non-oral infections (147) and serotype b strains are more frequently found in blood samples of patients with bacteremia or endocarditis compared with those with focal infections (150) . In a Japanese study, heart valve or aneurysmal tissue samples from patients with infective endocarditis, other valvular disease, or a thoracic or abdominal aneurysm were collected and the researchers concluded that the distribution of the A. actinomycetemcomitans serotype in the cardiovascular specimens differed from that normally seen in Japanese subjects without cardiac disease (151) . We recently showed that serotypes b and c were more frequently recognized in patients with CAD than in the non-CAD reference group and that those serotypes were associated with increased risk of stable CAD. Both the quantities of bacteria and serum antibody levels against A. actinomycetemcomitans were highest in patients harbouring serotype c, and the lowest antibody levels were detected in patients with serotype a (152) . It has also been shown, in vitro, that LPS from different strains of A. actinomycetemcomitans differ in their proatherogenic properties (153) , further supporting the idea of the diverse virulence potential among A. actinomycetemcomitans serotypes.
Conclusions
Both direct and indirect mechanisms are involved in putative periodontitis-induced atherosclerosis; the hypotheses and molecules involved are presented in Fig. 1 . As a result of oral inflammation, patients are continuously exposed to dysbiotic bacteria and their virulence factors that induce and sustain systemic lowgrade inflammation. Bacteremia and endotoxemia combined with immune dysfunction in susceptible subjects 
